ArticleFrontiers in immunology2026
Intestinal pooling of taurine conjugated bile acids is associated with tissue aging and senescent immune evasion.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aging drives metabolic decline and the accumulation of senescent cells that evade immune clearance. The mechanisms linking host-microbiome co-metabolism to peripheral tissue deterioration remain unclear. We hypothesized that age-dysregulated enterohepatic bile acid (BA) signaling directly promotes systemic aging and immune senescence. Methods: We conducted targeted BA metabolomics in the intestinal and peripheral compartments of young and middle-aged mice. To establish causality, 12-month-old mice underwent systemic BA depletion via a cholestyramine diet, followed by assessments of Farnesoid X Receptor (FXR) and Retinoic Acid Receptor alpha (RARα) signaling, cellular senescence, PD-L1/PD-L2 expression, and multi-organ transcriptomics. Results: Advancing age sequesters potent endogenous FXR antagonists (T-α-MCA, T-ω-MCA) within the gut lumen. However, peripheral tissues (lungs, skin, lymph nodes) progressively decrease in the levels of these regulatory molecules. This spatial disconnect triggers chronic peripheral FXR hyperactivation, disrupting local RARα signaling. which accelerates the accumulation of senescent cells and actively shields them from immune clearance by upregulating PD-L1 and PD-L2 surface checkpoints. Crucially, systemic BA sequestration reversed this phenotype. Depleting the pathological BA pool suppressed peripheral FXR overreaction. Further cleared the senescent burden, stripped senescent cells of their immune-evasive checkpoints, and drove a multi-organ of age-associated transcriptional changes. Conclusion: The age-altered BA metabolome may contribute to systemic aging and to upregulation of PD-L1 and PD-L2. Rebalancing the enterohepatic BA network to relieve peripheral FXR hyperactivation represents a potent, broad-spectrum geroprotective strategy to restore immune surveillance and multi-organ homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.